Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608
Published April 21, 2021 · Recall initiated: March 19, 2021
Summary
FDA records drug Class III recall D-0330-2021, published April 21, 2021 and initiated March 19, 2021. Recalling firm: Asclemed USA Inc. dba Enovachem Pharmaceuticals; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Distributor
- Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.
- Lot
- Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACandesartan Cilexetil Tablets, USP, 4 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA,April 21, 2021
- FDALidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey,April 21, 2021
- FDASHARP MEDICAL PRODUCTS, LLC Reactor and Sleeve REF 100-36-01 Size: AdultApril 14, 2021
- FDAEstriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36January 15, 2020
- FDAEstriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37January 15, 2020
- FDAEstriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-38January 15, 2020
Questions about this recall
Was Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608 recalled?
Yes. FDA published recall D-0330-2021 on April 21, 2021. Reported hazard: Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
What should I do if I have this product?
Voluntary: Firm initiated · Letter